316 related articles for article (PubMed ID: 23516510)
1. Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Zhang Y; Zhang Q; Yin J; Xie J; Shen Q; Deng Y; Ding Y; Li W; Li J; Zhang H; Cao G
PLoS One; 2013; 8(3):e58564. PubMed ID: 23516510
[TBL] [Abstract][Full Text] [Related]
2. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
[TBL] [Abstract][Full Text] [Related]
3. Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma.
Zhang Q; Ji XW; Hou XM; Lu FM; Du Y; Yin JH; Sun XY; Deng Y; Zhao J; Han X; Yang GS; Zhang HW; Chen XM; Shen HB; Wang HY; Cao GW
Ann Oncol; 2014 Dec; 25(12):2413-2419. PubMed ID: 25223483
[TBL] [Abstract][Full Text] [Related]
4. Association between Genetic Polymorphisms in MicroRNAs 196a2 (rs11614913) and 34 b/c (rs4938723) and Risk of Hepatocellular Carcinoma in Egyptian Patients.
Ibrahim AA; El-Feki MA; Gamal M; Doudar NA; Marey H; Abd El Ghany WM; Abdalla NH
Asian Pac J Cancer Prev; 2022 Apr; 23(4):1373-1377. PubMed ID: 35485699
[TBL] [Abstract][Full Text] [Related]
5. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
6. Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma.
Xie J; Zhang Y; Zhang Q; Han Y; Yin J; Pu R; Shen Q; Lu W; Du Y; Zhao J; Han X; Zhang H; Cao G
Hepatology; 2013 Jun; 57(6):2369-77. PubMed ID: 23386590
[TBL] [Abstract][Full Text] [Related]
7. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma.
Xu Y; Liu L; Liu J; Zhang Y; Zhu J; Chen J; Liu S; Liu Z; Shi H; Shen H; Hu Z
Int J Cancer; 2011 Jan; 128(2):412-7. PubMed ID: 20309940
[TBL] [Abstract][Full Text] [Related]
8. Phosphatase and tensin homologue genetic polymorphisms and their interactions with viral mutations on the risk of hepatocellular carcinoma.
Du Y; Zhang YW; Pu R; Han X; Hu JP; Zhang HW; Wang HY; Cao GW
Chin Med J (Engl); 2015 Apr; 128(8):1005-13. PubMed ID: 25881591
[TBL] [Abstract][Full Text] [Related]
9. Study of the association between five polymorphisms and risk of hepatocellular carcinoma: A meta-analysis.
Yu JY; Hu F; Du W; Ma XL; Yuan K
J Chin Med Assoc; 2017 Apr; 80(4):191-203. PubMed ID: 28188097
[TBL] [Abstract][Full Text] [Related]
10. HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population.
Zhao Y; Chen K; Yang H; Zhang F; Ding L; Liu Y; Zhang L; Zhang Y; Wang H; Deng Y
Virol J; 2023 Nov; 20(1):283. PubMed ID: 38037048
[TBL] [Abstract][Full Text] [Related]
11. Association between polymorphisms in the promoter region of pri-miR-34b/c and risk of hepatocellular carcinoma.
Chen LL; Shen Y; Zhang JB; Wang S; Jiang T; Zheng MQ; Zheng ZJ; Chen CX
Genet Mol Res; 2016 Oct; 15(4):. PubMed ID: 27808368
[TBL] [Abstract][Full Text] [Related]
12. Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Du Y; Han X; Pu R; Xie J; Zhang Y; Cao G
Front Med; 2014 Jun; 8(2):217-26. PubMed ID: 24748463
[TBL] [Abstract][Full Text] [Related]
13. HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations.
Zhang Q; Yin J; Zhang Y; Deng Y; Ji X; Du Y; Pu R; Han Y; Zhao J; Han X; Zhang H; Cao G
J Virol; 2013 Nov; 87(22):12176-86. PubMed ID: 24006435
[TBL] [Abstract][Full Text] [Related]
14. Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinoma.
Son MS; Jang MJ; Jeon YJ; Kim WH; Kwon CI; Ko KH; Park PW; Hong SP; Rim KS; Kwon SW; Hwang SG; Kim NK
Gene; 2013 Jul; 524(2):156-60. PubMed ID: 23632240
[TBL] [Abstract][Full Text] [Related]
15. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375
[TBL] [Abstract][Full Text] [Related]
16. Association of four common SNPs in microRNA polymorphisms with the risk of hepatocellular carcinoma.
Li X; Li K; Wu Z
Int J Clin Exp Pathol; 2015; 8(8):9560-6. PubMed ID: 26464719
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus genotypes, expression quantitative trait loci for ZNRD1-AS1 and their interactions in hepatocellular carcinoma.
Liu Z; Song C; Wen J; Xu L; Liu Y; Zhu J; Zhu L; Hu Z; Ma H; Liu L
Oncotarget; 2016 Jul; 7(28):44076-44083. PubMed ID: 27286450
[TBL] [Abstract][Full Text] [Related]
18. pri-miR-34b/c rs4938723 polymorphism is associated with hepatocellular carcinoma risk: a case-control study in a Chinese population.
Liu CJ; Ma XW; Zhang XJ; Shen SQ
Int J Mol Epidemiol Genet; 2017; 8(1):1-7. PubMed ID: 28337312
[TBL] [Abstract][Full Text] [Related]
19. Predictive role of miR-146a rs2910164 (C>G), miR-149 rs2292832 (T>C), miR-196a2 rs11614913 (T>C) and miR-499 rs3746444 (T>C) in the development of hepatocellular carcinoma.
Yan P; Xia M; Gao F; Tang G; Zeng H; Yang S; Zhou H; Ding D; Gong L
Int J Clin Exp Pathol; 2015; 8(11):15177-83. PubMed ID: 26823863
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive assessment for miRNA polymorphisms in hepatocellular cancer risk: a systematic review and meta-analysis.
Wang BG; Jiang LY; Xu Q
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29976775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
